In this context, interest has emerged in incretin receptor agonists as potential modulators of pulmonary fibrotic pathways, although the supporting evidence remains preliminary
The authors noted that well-designed, adequately powered clinical trials were lacking, and that definitive efficacy claims could not be supported by the existing literature at the time of publication
Restricting the suspicion of postprandial hypoglycemia to those who reported more serious symptoms, including needing third-party assistance, the prevalence was 11.6%
Setria Setria is a patented trademark of Kyowa Hakko Kogyo Co
Anagnostakis, F., Kokkorakis, M., Anastasiou, G., Nagarajan, S